Presented by: James Q. Del Rosso, DO, FAOCD
Eligible for up to One (1) AOA Category 1A CME or One (1) AMA PRA Category 1™ Credit
- Discuss current advances in understanding the pathophysiology of atopic dermatitis and correlate selected therapies and modes of action with clinical results.
Explain more recent approach to the management of rosacea correlating phenotype presentation with therapeutic options.
Review therapeutic advances in acne management with both topical and oral therapies.
- New methods of diagnosis or treatment
- Availability of new medication(s) or indication(s)
- Advances in medical knowledge
- Del Rosso JQ, Tanghetti E, et al. “Update on the Management of Rosacea from the American Acne & Rosacea Society (AARS).” J Clin Aesther Dermatol. 2019;12(6).
- Del Rosso JQ. “Nonsteroidal Topical Therapy for Atopic Dermatitis.” J Clin Aesthet Dermatol. 2020;13(5):44-48.
- See Pub Med Central under Del Rosso JQ for several other peer-reviewed and indexed references.
Core Competencies: 2, 3, 4, 6
James Q. Del Rosso, DO, FAOCD
Dr. James Q. Del Rosso, DO, FAOCD, FAAD, was born in Brooklyn, New York, and attended pharmacy school at St. John’s University in Jamaica, New York. He completed a hospital pharmacy residency at Temple University in Philadelphia, PA. Dr. Del Rosso graduated from medical school at Ohio University with honors and then completed his approved dermatology residency at the Atlantic Skin Disease Association in Fort Lauderdale, Florida.
He additionally completed a fellowship approved by the American College of Mohs Surgery in Mohs Micrographic Surgery and Cutaneous Oncology at Ohio State. Dr. Del Rosso is board certified in Dermatology and Mohs Micrographic Surgery and is fully licensed in the State of Nevada.
Dr. Del Rosso is an internationally renowned educator and speaker with several publications in recognized dermatology journals. He is a frequently invited presenter at major dermatology meetings in both the United States and globally, often talking about what is new in therapeutics and drug development. Additionally, he has written and published several articles on a variety of skin diseases including proper care of the skin barrier, acne, rosacea, psoriasis, atopic dermatitis, and eczemas, actinic keratosis, and skin cancers. He is also the co-editor of the textbook, Acne Vulgaris.
He is a past president of the American Acne & Rosacea Society, the American Society for Mohs Surgery, and the American Osteopathic College of Dermatology. He is editor-in-chief of the Journal of Clinical Aesthetic Dermatology since its inception in 2005. He has also authored several recognized publications on guidelines for management of acne, rosacea, atopic dermatitis, psoriasis, and skin cancer.
He founded the Scientific Panel for Antibiotic Use in Dermatology in 2005, with three meetings and scientific publications authored by the group under his direction to guide clinicians on optimal antibiotic use.
Dr. Del Rosso is research director and principal investigator of JDR Dermatology Research, in addition to having his dermatology clinic that is fully dedicated to the care of people with skin disorders or have concerns about their skin. The research center conducts studies for a wide variety of skin conditions, such as acne, rosacea, psoriasis, eczemas, urticaria, actinic keratosis, and skin cancer. Dr. Del Rosso has over 25 years of experience in dermatology research and related publications, and he employs a highly experienced and skilled staff. Dr. Del Rosso is in dermatology practice at Thomas Dermatology in Las Vegas, Nevada. He has been practicing dermatology in the Las Vegas area for 20 years.
Dr. Del Rosso was the recipient of a lifetime achievement award by the American Academy of Dermatology (AAD) in March 2016 for his lifelong commitment to dermatology and his contributions to the field. He now has the distinguished title of Honorary Member with the Academy.
Outside of his professional activities, Dr. Del Rosso is an avid lover of music and sports. He is the proud owner of what can be considered to be a “museum” of sports memorabilia and rock and roll music memorabilia, including a collection of limited edition guitars and vintage guitars. He also attends many concerts, usually sitting in the first row middle section. His motto about attending concerts is admittedly a selfish one: “The concert is being put on specifically for me…I am just nice enough to let everyone else in”. In 2015, Dr. Del Rosso recorded a CD entitled “My Royal Dream by Dr. D and the LL-7”, at the legendary Royal Studios in Memphis, Tennessee. The producer and recording engineer of this CD was Lawrence “Boo” Mitchell, who has recorded several major artists, and won a Grammy Award for being the recording engineer for “Uptown Funk” by Bruno Mars, which was also recorded at Royal Studios. Dr. Del Rosso is proud to say he is a good father and a “very cool” grandfather. The loves of his life are his wife Karyn, his daughter Jaclyn, his sister Marilyn and brother-in-law Pat, his stepchildren Chrystyna and Ron, his son-in-law David, and his grandchildren Allyson, Blake, Emily, and Asher. He is also thankful for having had great parents and loves his inner circle of great loyal friends. Dr. Del Rosso is proud and happy to say, “I have no bucket list. I have done everything I have wanted to do and I believe it has always been done well. It is time for the icing on the cake at this point in my life. I do what I enjoy and get great pleasure in giving back through personal generosity and the professional work that I do. My hope is to record another CD with Boo Mitchell. That was the greatest week of my life”.
Disclosures: Research investigator for: Aclaris, Almirall, Amgen (Celgene), Anaptys Bio, Arcutis, Athenex, Bausch (Ortho Dermatology), Biopharmx, Biorasi, Botanix, Cara Therapeutics, Cassiopeia, Epi Health, Foamix/Menlo, Galderma,
Genentech, Incyte, Leo Pharma, Lilly (Dermira), Novan, Pfizer, Ralexar, Regeneron, Solgel, Sun Pharma
Consultant/Advisor for: Aclaris, Almirall, Amgen (Celgene), Bausch (Ortho Dermatology), Biofrontera, Biopharmx, Cassiopeia, Encore, Epi Health, Ferndale, Foamix/Menlo, Galderma, Leo Pharma, La Roche Posay, Lilly (Dermira), MC2, Novan, Pfizer, Regeneron,
Sanofi-Genzyme, Solgel, Sonoma (Intraderm), Sun Pharma, Verrica
Speaker: Aclaris, Almirall, Amgen (Celgene), Bausch (Ortho Dermatology), Biofrontera, Encore, Epi Health, Ferndale, Galderma, Genentech, Leo Pharma, Lilly (Dermira), Pfizer, Regeneron, Sanofi-Genzyme, Sun Pharma, Verrica
More Upcoming Wednesday Webinars:
October 21, 2020
Bradley Glick, DO, FAOCD
November 4, 2020
Primary Care Dermatology
James Landero, DO, FAOCD
December 2, 2020
Third World Dermatology
G. Scott Drew, DO, FAOCD
December 9, 2020
Update on Eczema Atopic Skin
James Q. Del Rosso, DO, FAOCD
The American Osteopathic College of Dermatology (AOCD) is accredited by the American Osteopathic Association (AOA) to provide Category 1A continuing medical education for physicians.
The American Osteopathic College of Dermatology (AOCD) designates this program for a maximum of 1 AOA Category 1-A credits and will report CME and specialty credits commensurate with the extent of the physician’s participation in this activity.
The American Osteopathic College of Dermatology (AOCD) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide AMA PRA Category 1 Credits™ continuing medical education for physicians.
The American Osteopathic College of Dermatology (AOCD) designates this program for a maximum of 1 AMA PRA Category 1 Credit™, and will report CME and specialty credits commensurate with the extent of the physician’s participation in this activity.
All webinar presentations are funded in total by the American Osteopathic College of Dermatology. No commercial support is received for production, presentation/webcast, speaker honorarium, or any other purpose. Speakers are instructed to refrain from using product brand names, using company names, and displaying any commercial bias in their presentations.